S&P 500   4,590.52 (+0.85%)
DOW   35,712.89 (+0.63%)
QQQ   383.17 (+0.83%)
AAPL   152.55 (+2.49%)
MSFT   322.34 (-0.26%)
FB   313.10 (+0.28%)
GOOGL   2,906.01 (-0.63%)
TSLA   1,068.74 (+2.98%)
AMZN   3,437.55 (+1.33%)
NVDA   247.40 (+1.18%)
BABA   169.43 (+0.12%)
NIO   39.75 (+1.12%)
CGC   13.11 (+2.58%)
GE   104.43 (+0.56%)
AMD   122.00 (-0.23%)
MU   69.78 (+2.26%)
T   25.53 (+1.88%)
F   16.86 (+8.70%)
ACB   6.99 (+2.19%)
DIS   170.04 (+0.29%)
PFE   43.34 (+0.86%)
BA   206.27 (-0.16%)
AMC   35.23 (+1.35%)
S&P 500   4,590.52 (+0.85%)
DOW   35,712.89 (+0.63%)
QQQ   383.17 (+0.83%)
AAPL   152.55 (+2.49%)
MSFT   322.34 (-0.26%)
FB   313.10 (+0.28%)
GOOGL   2,906.01 (-0.63%)
TSLA   1,068.74 (+2.98%)
AMZN   3,437.55 (+1.33%)
NVDA   247.40 (+1.18%)
BABA   169.43 (+0.12%)
NIO   39.75 (+1.12%)
CGC   13.11 (+2.58%)
GE   104.43 (+0.56%)
AMD   122.00 (-0.23%)
MU   69.78 (+2.26%)
T   25.53 (+1.88%)
F   16.86 (+8.70%)
ACB   6.99 (+2.19%)
DIS   170.04 (+0.29%)
PFE   43.34 (+0.86%)
BA   206.27 (-0.16%)
AMC   35.23 (+1.35%)
S&P 500   4,590.52 (+0.85%)
DOW   35,712.89 (+0.63%)
QQQ   383.17 (+0.83%)
AAPL   152.55 (+2.49%)
MSFT   322.34 (-0.26%)
FB   313.10 (+0.28%)
GOOGL   2,906.01 (-0.63%)
TSLA   1,068.74 (+2.98%)
AMZN   3,437.55 (+1.33%)
NVDA   247.40 (+1.18%)
BABA   169.43 (+0.12%)
NIO   39.75 (+1.12%)
CGC   13.11 (+2.58%)
GE   104.43 (+0.56%)
AMD   122.00 (-0.23%)
MU   69.78 (+2.26%)
T   25.53 (+1.88%)
F   16.86 (+8.70%)
ACB   6.99 (+2.19%)
DIS   170.04 (+0.29%)
PFE   43.34 (+0.86%)
BA   206.27 (-0.16%)
AMC   35.23 (+1.35%)
S&P 500   4,590.52 (+0.85%)
DOW   35,712.89 (+0.63%)
QQQ   383.17 (+0.83%)
AAPL   152.55 (+2.49%)
MSFT   322.34 (-0.26%)
FB   313.10 (+0.28%)
GOOGL   2,906.01 (-0.63%)
TSLA   1,068.74 (+2.98%)
AMZN   3,437.55 (+1.33%)
NVDA   247.40 (+1.18%)
BABA   169.43 (+0.12%)
NIO   39.75 (+1.12%)
CGC   13.11 (+2.58%)
GE   104.43 (+0.56%)
AMD   122.00 (-0.23%)
MU   69.78 (+2.26%)
T   25.53 (+1.88%)
F   16.86 (+8.70%)
ACB   6.99 (+2.19%)
DIS   170.04 (+0.29%)
PFE   43.34 (+0.86%)
BA   206.27 (-0.16%)
AMC   35.23 (+1.35%)
NASDAQ:BMRA

Biomerica Earnings Date, Estimates, & History

$4.56
+0.08 (+1.79 %)
(As of 10/28/2021 10:33 AM ET)
Add
Compare
Today's Range
$4.56
$4.87
50-Day Range
$3.90
$6.71
52-Week Range
$3.30
$8.15
Volume
501 shs
Average Volume
865,595 shs
Market Capitalization
$57.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.68

Earnings Summary

Upcoming
Earnings Date
Jan. 13
Estimated

Actual EPS
(Oct. 15)
-$0.12

Consensus EPS
(Oct. 15)
-$0.12

Last Year's Q4 EPS
(10/15/2020)
-$0.14

Skip Charts & View Estimated and Actual Earnings Data

Biomerica Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Biomerica Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Biomerica (NASDAQ:BMRA) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.09)$0.00($0.05)
Q2 20213($0.13)($0.05)($0.10)
Q3 20212($0.03)($0.01)($0.02)
Q4 20212($0.09)($0.03)($0.06)
FY 20219($0.34)($0.09)($0.22)
Q1 20221($0.12)($0.12)($0.12)
Q2 20221($0.08)($0.08)($0.08)

BMRA Earnings Information

Biomerica last issued its quarterly earnings results on October 15th, 2021. The reported ($0.12) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.12). Biomerica has generated ($0.54) earnings per share over the last year (($0.54) diluted earnings per share). Biomerica has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 13th, 2022 based off prior year's report dates.

Biomerica (NASDAQ:BMRA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
1/13/2022
(Estimated)
        
10/15/2021Q1($0.12)($0.12)($0.12)
8/27/2021Q4 2021($0.10)($0.12)($0.02)($0.12)$2.85 million$1.05 million
4/29/2021Q3($0.08)($0.15)($0.07)($0.15)
4/14/2021Q3 2021($0.02)($0.15)($0.13)($0.15)$2.36 million$3.63 million
1/15/2021Q2($0.0980)($0.13)($0.0320)($0.13)$1.56 million$1.37 million
10/15/2020Q1($0.08)($0.14)($0.06)($0.14)$1.09 million$1.14 million
9/1/2020Q4($0.0670)($0.04)+$0.0270($0.04)$2.73 million
4/14/2020Q3($0.0650)($0.09)($0.0250)($0.09)$1.35 million$1.18 million
1/15/2020Q2 2020($0.08)($0.0494)+$0.0306($0.05)$1.69 million$1.60 million
10/16/2019Q1 2020($0.06)($0.0520)+$0.0080($0.05)$1.52 million$1.19 million
8/30/2019Q4($0.08)($0.08)($0.08)$1.36 million$1.17 million
4/15/2019Q3 2019($0.05)($0.0728)($0.0228)($0.07)$1.58 million$1.26 million
1/15/201911/30/2018($0.06)($0.05)+$0.01($0.05)$1.51 million$1.50 million
10/16/2018Q1 2019($0.06)($0.0510)+$0.0090($0.05)$1.38 million$1.27 million
8/30/2018Q4 2018($0.06)($0.08)($0.02)($0.08)$1.53 million$1.13 million
4/16/2018Q3 2018($0.06)($0.0380)+$0.0220($0.04)$1.56 million$1.38 million
1/16/2018Q2 2018($0.04)($0.03)+$0.01($0.03)$1.48 million$1.61 million
10/16/2017Q1 2018($0.03)($0.02)+$0.01($0.02)$1.52 million$1.44 million
8/30/2017Q4 2017($0.02)($0.04)($0.02)($0.04)$1.47 million$1.45 million
4/14/2017Q3 2017($0.03)($0.04)($0.01)($0.04)$1.39 million$1.50 million
1/17/2017Q2 2017($0.03)($0.02)+$0.01($0.02)$1.17 million$1.43 million
10/17/2016Q1 2017($0.03)($0.01)+$0.02($0.01)$1.26 million$1.41 million
8/30/2016Q4 2016($0.01)($0.16)($0.15)($0.16)$1.32 million$1.33 million
4/14/2016Q3 2016($0.02)($0.02)($0.02)$1.52 million$1.36 million
1/14/2016Q2 2016($0.02)($0.01)+$0.01($0.01)$1.49 million$1.17 million
10/15/2015Q1 2016($0.02)($0.01)+$0.01($0.01)$1.32 million$1.29 million
9/1/2015Q4 2015$0.03+$0.03$0.03$1.42 million$1.49 million
4/15/2015Q3 2015($0.01)($0.02)($0.01)($0.02)$1.50 million$1.30 million
1/15/2015Q2 2015($0.01)($0.03)($0.02)($0.03)$1.40 million$1.13 million
10/16/2014Q1 2015($0.03)($0.03)($0.03)$1.24 million$1.03 million  
9/2/2014Q4 2014$0.02$0.02$0.02$1.43 million$1.68 million
1/15/2014Q2 2014($0.01)($0.03)($0.02)($0.03)$1.16 million$0.94 million
10/15/2013Q1 2014($0.02)($0.02)($0.02)$1.43 million$1.01 million
8/29/2013Q4 2013$0.01+$0.01$0.01$1.47 million
4/15/2013Q3 2013$0.03($0.01)($0.04)($0.01)$1.77 million$1.42 million
1/14/2013Q2 2013$0.03+$0.03$0.03
10/15/2012Q1 2013$0.04+$0.04$0.04
8/29/2012Q4 2012$0.01+$0.01$0.01
4/17/2012Q3 2012$0.03+$0.03$0.03
1/17/2012Q2 2012$0.03+$0.03$0.03
10/18/2011Q1 2012$0.02+$0.02$0.02
8/30/2011Q4 2011$0.01+$0.01$0.01
4/15/2011Q3 2011$0.01+$0.01$0.01
4/15/2010Q3 2010$0.02+$0.02$0.02
1/19/2010Q2 2010($0.05)($0.05)($0.05)
(Earnings results data provided by Zacks Investment Research)












Biomerica (NASDAQ:BMRA) Earnings Frequently Asked Questions

When is Biomerica's earnings date?

Biomerica has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 13th, 2022 based off last year's report dates. Learn more on BMRA's earnings history

Did Biomerica beat their earnings estimates last quarter?

In the previous quarter, Biomerica (NASDAQ:BMRA) reported ($0.12) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.12). Learn more on BMRA's earnings details

How much revenue does Biomerica generate each year?

Biomerica (NASDAQ:BMRA) has a recorded annual revenue of $7.20 million.

How much profit does Biomerica generate each year?

Biomerica (NASDAQ:BMRA) has a recorded net income of -$6.47 million. BMRA has generated -$0.54 earnings per share over the last four quarters.

This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.